Novavax
NVAX
#5751
Rank
โ‚ฌ0.96 B
Marketcap
5,93ย โ‚ฌ
Share price
0.73%
Change (1 day)
-24.31%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of September 2025 : -โ‚ฌ0.14 Billion

According to Novavax's latest financial reports the company has -โ‚ฌ0.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚ฌ0.6 Billion-7.56%
2023-12-31$-โ‚ฌ0.65 Billion9.71%
2022-12-31$-โ‚ฌ0.6 Billion90.36%
2021-12-31$-โ‚ฌ0.32 Billion-160.9%
2020-12-31$โ‚ฌ0.50 B-407.09%
2019-12-31$-โ‚ฌ0.17 Billion13.12%
2018-12-31$-โ‚ฌ0.15 Billion73.14%
2017-12-31$-โ‚ฌ84.79 Million1508.07%
2016-12-31$-โ‚ฌ5.28 Million-101.97%
2015-12-31$โ‚ฌ0.26 B41.77%
2014-12-31$โ‚ฌ0.18 B28.29%
2013-12-31$โ‚ฌ0.14 B142.6%
2012-12-31$โ‚ฌ60.66 M46.29%
2011-12-31$โ‚ฌ41.46 M-6.6%
2010-12-31$โ‚ฌ44.39 M-9.07%
2009-12-31$โ‚ฌ48.82 M50.05%
2008-12-31$โ‚ฌ32.53 M-24.66%
2007-12-31$โ‚ฌ43.19 M-39.37%
2006-12-31$โ‚ฌ71.23 M69.96%
2005-12-31$โ‚ฌ41.91 M70.84%
2004-12-31$โ‚ฌ24.53 M-14.06%
2003-12-31$โ‚ฌ28.54 M269.68%
2002-12-31$โ‚ฌ7.72 M-75.19%
2001-12-31$โ‚ฌ31.13 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-โ‚ฌ0.25 Billion 79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.13 B-942.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.50 B-471.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.34 Billion 147.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ39.48 B-29,442.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ79.96 B-59,520.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ38.43 B-28,664.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚ฌ6.45 M-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ18.18 B-13,616.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ0.51 B-481.92%๐Ÿ‡บ๐Ÿ‡ธ USA